NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Contract Research Orgs » Sundia MediTech Company,Ltd.  1    
found files: 17
Sundia MediTech Company,Ltd. »06/06/2007 [Company watch]
China CROs Merge

Sundia MediTech and Shanghai United PharmaTech report that they will be merging. This is a first for China‚Äôs young CRO industry, acording to Sundia‚Äôs CEO, Wang Xiaochuan, Ph.D. Both Xiaochuan and United PharmaTech‚Äôs CEO, Shi Xiongwei, Ph.D., signed a letter of intent agreeing to combine their two companies. Under the terms of the merger, both United PharmaTech and Sundia MediTech will become subsidiaries of Sundia Investment Group, the British Virgin Islands-based holding company that currently owns Sundia MediTech. Dr. Wang will become the new company‚Äôs chairman and CEO, while Dr. Shi will hold the positions of director and executive vp. The former senior management teams of both companies will join together into a new, combined management team. Zhang Suyang, a partner of IDG VC, said that he believes China‚Äôs drug development CRO industry is beginning to emerge from its initial state into one in which companies will begin to consolidate. ‚ÄúThe CRO companies, and the overall size of the CRO industry in China are still relatively small, and there is huge potential for growth, so we can expect that in the following few years there will be many mergers,‚ÄĚ explained Zhang. ‚ÄúCompanies in this industry will grow quickly and soon; we will see companies of reasonable size and with good governance emerge as corporations with serious long-term potential.‚ÄĚ Part of the reason for the merger, noted Dr. Wang, is that it will combine United PharmaTech‚Äôs and Sundia‚Äôs technical expertise in different fields....   more»

Sundia MediTech Company,Ltd. »08/06/2007 [Company watch]
Sundia Meditech Company, Ltd. celebrated its recent strong growth at the company's third anniversary party in Shanghai.

The main business of this company is to provide contracted research (CRO) services to pharmaceutical and biotech company clients worldwide. Earlier this week, the company announced a merger in process with United Pharmatech Company, another CRO company in Shanghai....   more»

Sundia MediTech Company,Ltd.
»12/07/2007 [Company watch]
CRO Company Sundia Named One of China\\\'s Top 50 to Invest In

Today, Sundia MediTech (Shanghai) Company was named one of the 50 best companies for investment in China by the top venture capital investors. Sundia ranked #16 of Venture 50, an event organized by Zero2IPO, an advisory firm for China investment....   more»

Sundia MediTech Company,Ltd. »17/01/2008 [Company watch]
CRO Company Sundia Welcomes New Members to Its Executive Team

Sundia MediTech (Shanghai) Company recently announced a welcome addition of new members to its executive team: Dr. Joseph Zhu and Dr. Shu Gao. Dr. Zhu is appointed as the Vice President of Medicinal Chemistry, while Dr. Gao as the Vice President in charge of Chemical Synthesis business....   more»

Sundia MediTech Company,Ltd. »18/02/2008 [Company watch]
European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions

Today, NovaSecta, Sundia Meditech and HD BioSciences announced their strategic alliance to provide drug discovery solutions for European pharmaceutical and biotech companies. This alliance brings together the high quality scientific capabilities of Sundia and HD BioSciences with NovaSecta's extensive client base and unique understanding of European mid-sized pharmaceutical and biotech companies...   more»

Sundia MediTech Company,Ltd. »02/05/2008 [Company watch]
Shanghai CRO Service Alliance Adds Clinical Development Capabilities

Today, Tigermed Consulting Ltd. joins Sundia Meditech, HD BioSciences, and NovaSecta in their CRO Service Alliance CROSA that provides R&D solutions for pharmaceutical and biotech companies. Tigermed's expertise in clinical development complements the existing drug discovery and pharmaceutical development capabilities of the alliance. Sundia Meditech, United PharmaTech, and HD BioSciences entered into a CRO Service Alliance in May 2007 in order to quickly and successfully integrate their chemistry and biology expertise for the increased demands from their clients world-wide. Sundia and United merged into one company in the following months. NovaSecta joined the alliance in February 2008 to further integrate the alliance's work with European pharmaceutical and biotech companies. Tigermed has a strong track record of providing clinical development services, data management and statistical support to multinational and smaller to medium sized pharmaceutical and biotech companies in US, Europe and Asia. Tigermed is also the clear leader in performing clinical trials in China on innovative New Chemical Entities (NCEs), which makes it an excellent potential partner for the pharmaceutical and biotech companies that Sundia, HD BioSciences and NovaSecta work with. Through the addition of Tigermed to the alliance, clients can now benefit from a seamlessly integrated full R&D service covering discovery, non-clinical and clinical development....   more»

Sundia MediTech Company,Ltd. »31/10/2008 [Company watch]
Sundia Named To Deloitte Fast 50 China

Sundia MediTech Company, a Shanghai CRO, was included in the Deloitte Technology Fast 50 China list, placing number 16. It was the second year in a row that Sundia was given the Fast 50 award. As a Fast 50 winner, Sundia will automatically be put in contention for the Deloitte Fast 500 Asia Pacific competition....   more»

Sundia MediTech Company,Ltd. »11/02/2009 [Company watch]
Zhangjiang Park and CRO Sundia MediTech Form Incubator

Shanghai Zhangjiang (Group) Co., which operates the Zhangjiang Hi-Tech Park, has joined with CRO Sundia MediTech Company to expand the concept of a CRO....   more»

Sundia MediTech Company,Ltd. »11/02/2009 [Company watch]
Sundia MediTech in Deloitte Technology Fast 500 Asia Pacific List

Sundia MediTech, a pharmaceutical R&D outsourcing service company in China, was selected in Deloitte Technology Fast 500 Asia Pacific list....   more»

Sundia MediTech Company,Ltd. »20/05/2009 [Company watch]
Finland Biotech Delegation Visits Sundia

A Finland Biotech Delegation visited Sundia MediTech Company, a leading pharmaceutical R&D outsourcing CRO service company in Shanghai, China, in April....   more»

Sundia MediTech Company,Ltd. »28/06/2009 [Industry news]
Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai

Shanghai Pudong Customs, Pudong International Airport Customs and Zhangjiang Group Co. held ceremony in the Zhangjiang Hi-Tech Park to initiate the Express Customs Clearance for 3 biopharmaceutical R&D outsourcing (CRO) companies....   more»

Sundia MediTech Company,Ltd. »06/07/2009 [Industry news]
Dr Chen joins Sundia chemistry services team

Sundia MediTech, an integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China, has appointed Dr Chen Chen as the Senior Vice President of Chemistry Services....   more»

Sundia MediTech Company,Ltd. »07/07/2009 [Company watch]
Sundia acquires PFSC technology

Sundia MediTech, an integrated pharmaceutical and biotech R&D outsourcing company in Shanghai, China has acquired Protein Folding Shape Code (PFSC) technology for doing probe binding site for drug discovery from Microtech Nano, a R&D company in Indianapolis, US. As part of this business deal, Dr Jiaan Yang, the founder and President of Microtech Nano joins Sundia as Vice President of Drug Discovery Technology....   more»

Sundia MediTech Company,Ltd.
»20/07/2009 [Company watch]
Sundia in Top 100 Fast-growth Outsourcing Companies in China

Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, announced today that the company was named as a Top 100 Fast-growth Outsourcing Service Provider. This selection was jointly sponsored by China Council for International Investment Promotion (CCIIP) and three global leading market researchers, TPI, IDC and Gartner....   more»

Sundia MediTech Company,Ltd.
»01/09/2009 [Industry news]
Sundia gets the (Highest Growth Potential) award

Sundia MediTech, a pharmaceutical R&D outsourcing company in China, has received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26....   more»

Sundia MediTech Company,Ltd. »16/10/2009 [Company watch]
Sundia appoints Senior VP of Sales and Marketing

Sundia MediTech, a leading pharmaceutical R&D outsourcing service company in China, has announced that Mr Charles D Maher has been appointed Senior Vice President of Sales and Marketing of Sundia....   more»

Sundia MediTech Company,Ltd. »11/03/2010 [Independent reports]
Lady behind Sundia success: Dr Xiaochuan Wang, China

Sundia, a Shanghai-based integrated pharmaceutical contract research organization is the brainchild of a highly motivated Chinese researcher, Dr Xiaochuan Wang, who worked in the US for over 14 years in three biotech companies after her PhD in molecular structure design of new drugs, from the University of Chicago....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.